Bill Summary

HB 885 Prescription Drugs Used in the Treatment of Schizophrenia for Medicaid Recipients (2022 Session)
Prescription Drugs Used in the Treatment of Schizophrenia for Medicaid Recipients: Authorizes approval of drug products or certain medication prescribed for treatment of schizophrenia or schizotypal or delusional disorders for Medicaid recipients who have not met step-therapy prior authorization criteria under certain circumstances. Effective Date: July 1, 2022
12/09/21
HOUSE 
Filed
01/03/22
HOUSE 
Referred to Finance & Facilities Subcommittee; Health Care Appropriations Subcommittee; Health & Human Services Committee
01/03/22
HOUSE 
Now in Finance & Facilities Subcommittee
02/04/22
HOUSE 
On Committee agenda - Finance & Facilities Subcommittee, 02/08/22, 1:00 pm, 17 H
02/08/22
HOUSE 
Favorable by Finance & Facilities Subcommittee; 15 Yeas, 0 Nays
02/08/22
HOUSE 
Now in Health Care Appropriations Subcommittee
02/10/22
HOUSE 
On Committee agenda - Health Care Appropriations Subcommittee, 02/14/22, 1:30 pm, 17 H
02/14/22
HOUSE 
Favorable by Health Care Appropriations Subcommittee; 12 Yeas, 0 Nays
02/14/22
HOUSE 
Now in Health & Human Services Committee
02/21/22
HOUSE 
On Committee agenda - Health & Human Services Committee, 02/23/22, 9:00 am, 17 H
02/23/22
HOUSE 
Favorable by Health & Human Services Committee; 17 Yeas, 0 Nays
02/23/22
HOUSE 
Placed on Calendar, on 2nd reading
02/28/22
HOUSE 
Placed on Special Order Calendar, 03/03/22
03/03/22
HOUSE 
Read Second Time; Substituted for SB 0534; Laid on Table, Refer to SB 0534
0885
Filed on 12/09/21
PDF
No amendments to this bill text filed.
Research & Reports
Revenue Estimating Coverence Reports, Veto, Transmittal letters and more. Learn more.

No reports related to this bill.

Upcoming Events
Florida's most comprehensive legislative calendar. Learn more.

No events are scheduled at this time.

Press Releases
Related Press Announcements. Learn more.

No press releases related to this bill.

Features above are available to LobbyTools subscribers. Request a free demo or call (850) 915-0100 ext. 2 to learn more.